Flo Health secures $200m investment to reach $1bn valuation

Flo Health, the number one downloaded women’s health app worldwide, has raised more than $200 million (£155.7m) in a Series C investment from General Atlantic, a leading global growth investor, propelling the company’s valuation beyond $1 billion (£783.1m).

The investment makes Flo Health the first purely digital consumer women’s health app to achieve unicorn status. Flo is committed to supporting women at every age of their health journey, from menstruation to conception, pregnancy, and menopause.

With over 120 doctors and health experts, Flo’s all-in-one platform offers curated cycle and ovulation tracking. Users can monitor over 70 symptoms and access various features designed to enhance their understanding and management of their health.

Flo also provides users with tailored health insights, expert tips, daily bite-sized visual content, and access to a private digital discussion community focused on health and wellness-related topics.

Flo’s partnership with General Atlantic will help position Flo for its next phase of growth, with a focus on expanding into new user segments including perimenopause and menopause, enhancing its tech-driven health insights, and pursuing strategic expansion opportunities.

Dimitry Gurski, co-founder and CEO of Flo Health, said: “Reaching unicorn status is a significant milestone for Flo and the entire femtech industry. When we started Flo, we identified a huge gap in women’s health services.

“Now, we’re a leader in a global movement to make women’s health a priority everywhere. We’re already helping hundreds of millions of women, and our goal is to reach one billion women through our global pro-social program.

“This initiative provides free access to Flo Premium across 66 countries, including India, Indonesia, and Nigeria, with nearly 12 million women already benefiting. We’re committed to building a better future for female health, where every woman feels understood and supported, regardless of her location or economic status.

“This investment from General Atlantic will help propel Flo Health’s growth as we continue normalising conversations about women’s health, improving health literacy, and raising awareness of women’s health issues worldwide, especially in underserved regions.”

Flo intends to increase R&D headcount with investments in top-tier talent across its global offices in Europe and North America, and to leverage General Atlantic’s significant expertise in scaling companies at the intersection of consumer technology, healthcare, and subscription business models.

Jessie Cai, principal at General Atlantic, said: “We have been lucky enough to watch the Flo team over the past five years build a beloved, mission-critical app for women globally, and now we have the fortunate opportunity to partner with Dmitry and his team.

“We are excited about their big vision and the innovation ahead for the broader women’s health and wellness ecosystem.

“We believe Flo is a category leader and look forward to leveraging our deep expertise across disruptive consumer technology and subscription platforms to support the company’s continued growth.”

Last year, delegates of a FemTech conference in London heard that the use of technology to address health problems across the lifecycle of women has found its moment, propelled by the desire of women to get access to their own health data and take control of their own health decisions.